Prevnar 13: Pneumococcal 13-valent Conjugate Vaccine
   

*Compared to Prevnar®
About the Importance of an Additional Dose of Prevnar 13®
Learn more

Home > Important Safety Information

Important Safety Information

IMPORTANT SAFETY INFORMATION FOR PREVNAR 13®

  • Prevnar 13® should not be given to anyone with a severe allergic reaction to any component of Prevnar 13®, Prevnar® (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) or any diphtheria toxoid–containing vaccine.
  • Prevnar 13® may not protect all individuals receiving the vaccine.
  • Protection against ear infections is expected to be less than that for invasive disease.
  • Children with weakened immune systems may have a reduced immune response to Prevnar 13®.
  • A temporary pause of breathing following vaccination has been observed in some infants born prematurely.
  • The most commonly reported serious adverse events include bronchiolitis (an infection of the lungs) (0.9%, 1.1%), gastroenteritis (inflammation of the stomach and small intestine) (0.9%, 0.9%), and pneumonia (0.9%, 0.5%) for Prevnar 13® and Prevnar®, respectively.
  • The most common side effects are redness, swelling and tenderness at the injection site, fever, decreased appetite, irritability, increased sleep, and decreased sleep. Any side effects associated with the vaccination should be reported to your child's health care provider.
  • Ask your child's health care provider about the risks and benefits of Prevnar 13®. Only a health care provider can decide if Prevnar 13® is right for your child.

Please see Prescribing Information for Prevnar 13® Adobe Reader

INDICATION FOR PREVNAR 13®

  • Prevnar 13® is a vaccine approved for use in children 6 weeks through 5 years of age (prior to the 6th birthday).
  • Prevnar 13® is indicated for active immunization for the prevention of invasive disease caused by 13 strains of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F).
  • Prevnar 13® is also indicated for the prevention of otitis media (ear infection) caused by 7 strains of Streptococcus pneumoniae (4, 6B, 9V, 14, 18C, 19F, and 23F). No efficacy data for ear infections are available for strains 1, 3, 5, 6A, 7F, and 19A.



Home  |  What is Prevnar 13®?  |  What is Pneumococcal Disease?
Broader Coverage* for Children Already Vaccinated with 4 Doses of Prevnar®  |  Vaccination Schedule For Prevnar 13®
Resources for Parents  |  Important Safety Information  |  Prescribing Information  |  For U.S. Healthcare Professionals  |  Contact Us  |  Sitemap

PREVNAR® and Prevnar 13® are registered trademarks of Wyeth LLC.
Wyeth Manufactured by Wyeth Pharmaceuticals Inc.   Marketed by Pfizer Inc.
262249-01   © 2010 Pfizer Inc.   All rights reserved.   August 2010
0
This site is intended only for residents of the United States.
All rights reserved.
Please read our Privacy Policy and Terms and Conditions.
The product information provided in this site is intended for residents of the United States.
The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only
and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
Small Medium Large